Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Urologic oncology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.urolonc.2009.01.002PMID 19269198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Common Variation in the BRCA1 Gene and Prostate Cancer Risk

  2007cited by this paper
• Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

  2007cited by this paper
• Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers

  2005cited by this paper
• Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.

  2004cited by this paper
• A novel soluble single-chain T-cell receptor IgG1 fusion protein retains MHC restricted peptide specific antigen binding and exhibits anti-tumor effects in vivo.

  2004cited by this paper
• Opportunities for cancer epidemiology in developing countries

  2004cited by this paper
• Bortezomib as a Potential Treatment for Prostate Cancer

  2004cited by this paper
• Nutrition and prostate cancer

  2004cited by this paper
• Functional and Physical Interactions between BRCA1 and p53 in Transcriptional Regulation of the IGF-IR Gene

  2003cited by this paper
• Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma

  2003cited by this paper
• The role of p53 mutation in BRCA1-associated ovarian cancer.

  2002cited by this paper
• Cancer and the Environment: Gene-Enviroment Interaction

  2002cited by this paper
• Nutrition and Risk of Prostate Cancer

  2002cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cited by this paper
• BRCA1 and Prostate Cancer

  2001cited by this paper
• The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

  2001cited by this paper
• NCI-Myriad agreement offers BRCA testing at reduced cost.

  2000cited by this paper
• Molecular genetics of prostate cancer.

  2000cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• Diet and Its Preventive Role in Prostatic Disease

  1999cited by this paper
• Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

  1999cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• Diet, nutrition, and prostate cancer.

  1998cited by this paper
• Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries.

  1997cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• In situ Hybridization

  1994cited by this paper
• p53 is mutated in a subset of advanced-stage prostate cancers.

  1993cited by this paper
• p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

  1993cited by this paper

• A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer

  2019cites this paper
• Evaluation of correlation between expression of P53 and Malondialdehyde levels in prostate cancer patients.

  2018cites this paper
• Cancer Biomarker Discovery: The Entropic Hallmark

  2010cites this paper
• Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression

  2010cites this paper